Dr. Cincotta is the founder of the company and is responsible for overseeing all research and development. He earned his PhD from Louisiana State University in biochemical physiology. He has over 27 successful years in clinical research and development and is recognized as one of the world's leading authorities on biological clock regulation of metabolism, metabolic syndrome and Circadian Neuroendrocrine Resetting Therapy.
Creators of Cycloset®*, the first and only FDA approved sympatholytic dopamine D2 receptor agonist for the treatment of type 2 diabetes.
*See full prescribing info
